GoodRx, a healthcare company that tracks prescription drug prices in the United States, reports that prices for 442 drugs have increased by an average 5.2% already this year.
GoodRx, a healthcare company that tracks prescription drug prices in the United States, reports that so far this year, prices for 442 drugs have increased by an average 5.2%. A second analysis by research firm 46Brooklyn shows similar results, with the median price for brand-name drugs rising 4.9%. Median, of course means that half of drug prices went up more than 4.9%, while half went up less.
The data covers more than 90 companies, including giants like Bayer, GlaxoSmithKline GSK, +0.14%, and Pfizer PFE, +2.02%, says GoodRx. The increases are for a wide range of both specialty and maintenance medications, including those for allergies, arthritis, asthma, cancer, heart disease, high blood pressure, and more.It’s important to note that these percentage increases are based on list prices—the price of a drug as it is set by the manufacturer.
Even before the New Year’s round of increases, a survey by the Kaiser Family Foundation said that nearly one in four Americans struggle with the cost of prescription drugs, “including larger shares among those with health issues, with low incomes and nearing Medicare age.” AARP added this ominous warning: “If brand-name drug price inflation continues unabated, a growing number of older Americans will face drug costs that exceed their median annual income and will not be able to take their medications as needed. This ever-expanding affordability problem will lead to poorer health outcomes and higher healthcare costs in the future.”
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Happy perihelion! Earth reaches its closest point to the sun of 2022Winter won't feel any warmer, though.
Lire la suite »
Tencent’s Sea rejig keeps most people happyThe Chinese tech behemoth is selling part of its stake in its $120 bln Singaporean peer. Sea also plans a revamp of its supervoting shares so that founder Forrest Li retains control. Li, Tencent and even Beijing can cheer. Minority investors have the least reason to be enthused.
Lire la suite »
Kim Kardashian Does Not Seem Happy With Miley Cyrus Getting Close to Pete DavidsonA recent 'unfollow' move by Kim Kardashian has many on the Internet wondering if there's tension between the mogul and singer, Miley Cyrus.
Lire la suite »
How to Be Happy in Middle Age and Avoid a Midlife Crisis4 ways to experience middle age as an adventure to be enjoyed rather than a challenge to be overcome, by AndreaBrandtPhD
Lire la suite »